Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyasha Pareek

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plastic and Reconstructive Surgery. Global Open|October 4, 2024
The Controversy over Price Transparency: Patients and Plastic Surgeons DisagreeParul Rai, Priyasha Pareek, Caitlyn L Vilas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2025
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. SouthJonathan A Colasanti, Amalia Aldredge, Larisa V Niles-Carnes, et al.
Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plastic and Reconstructive Surgery. Global Open|October 4, 2024
The Controversy over Price Transparency: Patients and Plastic Surgeons DisagreeParul Rai, Priyasha Pareek, Caitlyn L Vilas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2025
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. SouthJonathan A Colasanti, Amalia Aldredge, Larisa V Niles-Carnes, et al.
Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Pageof 1